Company intelligence / Profile preview
Sagmel
- Ownership
- Private
- Employees
- ~1000
- Development stage
- Other
Overview
Sagmel, Inc. was a privately held pharmaceutical company headquartered in Libertyville, Illinois, specializing in the development, manufacturing, and marketing of over-the-counter (OTC) medications and nutritional supplements. The company established a dominant market presence in the Commonwealth of Independent States (CIS), including Russia, Ukraine, Kazakhstan, and Belarus, where it became a leading provider of consumer health products. Its portfolio featured well-known brands such as Theraflex for joint health, Nazol for nasal congestion, and Relief for hemorrhoid treatment. In 2008, Sagmel was acquired by Bayer HealthCare for approximately €265 million, significantly expanding Bayer's footprint in the rapidly growing Eastern European and CIS markets. Following the acquisition, Sagmel's operations and brand assets were fully integrated into Bayer's Consumer Care division.
- Therapeutic areas
- EndocrinologyPulmonologyRheumatologyGastroenterologyMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Sagmel.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sagmel.